Nutrela Nutrition

India Listed
Nutritional and Ayurvedic products from Nutrela Nutrition.
Request Access
Report Incorrect Data
Page last updated

About Nutrela Nutrition

Nutrela Nutrition is a publicly listed company based in India. Nutritional and Ayurvedic products from Nutrela Nutrition. The company has 5,564 employees. Its Indian entity Patanjali Foods Limited reported revenue of ₹40,348 Cr. Nutrela Nutrition offers products and services including Nutritional Supplements and Ayurvedic Supplements. Its focus areas include Health and Wellness, Nutraceuticals, Dietary Supplements and Nutritional Products.

Company details

Patanjali Foods Limited is known for the production of certified organic and natural nutraceutical products that are based on Ayurvedic principles and scientific research. These products, including supplements for men, women, and children, are designed to address daily nutritional needs and promote health without relying on chemicals. A range of items such as proteins, vitamins, and herbal formulations is made available to support immunity, muscle health, and overall well-being in todays fast-paced lifestyle. Eco-friendly practices are adopted in their manufacturing processes to ensure safety and effectiveness.

Operational Areas
Healthcare → Alternative Medicine Products
Key Metrics
  • Market Cap
    ₹40,151 Cr

    PATANJALI · NSE

  • Share Price
    ₹374.90

    +1.60% today

  • Revenue
    ₹40,170 Cr

    FY 2025-26 · +19.0% YoY

  • EBITDA
    ₹1,557 Cr

    Margin 3.9%

  • Net Profit
    ₹1,951 Cr

    FY 2025-26 · +50.1% YoY

  • P/E (TTM)
    18.3x

    P/B 3.0x

  • ROE
    15.9%

    ROCE 12.0%

  • Debt / Equity
    0.15

    Interest cover 10.2x

  • Employee Count
    5,564

Products & Services of Nutrela Nutrition

Nutrela Nutrition offers a comprehensive portfolio of products and services, including Nutritional Supplements and Ayurvedic Supplements.

Nutritional Supplements
Health Products

Nutritional supplements are provided by Nutrela Nutrition to fulfill daily requirements for vitamins, proteins, and minerals, supporting overall health and wellness

Ayurvedic Supplements
Wellness Items

Ayurvedic supplements are offered by Nutrela Nutrition, incorporating herbal ingredients that are intended to enhance immunity, joint health, and anti-aging benefits

Apps and channels of Nutrela Nutrition

its YouTube channel Nutrela Nutrition has 4.11K subscribers and 30 videos.

Nutrela Nutrition
YouTube 4.11K subscribers 30 videos Howto & Style
Open channel

Videos from Nutrela Nutrition

The most watched videos on Nutrela Nutrition's YouTube channel, Nutrela Nutrition (4.11K subscribers). Click a video to play it here.

NUTRELA NUTRITION DAILY ACTIVE | TVC 40 SEC HINDI | SHAHID KAPOOR
6.6M views
Healthy Natural Nutrition for Men, Women & Diabetics
2.4M views
100% Veg & Natural Skin Superfood 1st time in India
1.7M views
Nutrela Weight Gain चुनें और एक महीने में 3-5 किलो वजन बढ़ाएं
1.4M views

More on Nutrela Nutrition.

Board of directors of Patanjali Foods Limited (Nutrela Nutrition)

Patanjali Foods Limited is the primary company behind Nutrela Nutrition. The board of Patanjali Foods Limited currently have 8 directors; the longest-serving is Girish Kumar Ahuja, appointed in 2019. 23 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Girish Kumar Ahuja
DIN 00446339
Director18 Dec 20196 yrs 10 moPatanjali Foods Limited
Acharya Balkrishna
DIN 01778007
Director18 Dec 20196 yrs 10 moPatanjali Foods Limited
Ram Bharat
DIN 01651754
Managing Director18 Dec 20196 yrs 10 moPatanjali Foods Limited
Swami Ramdev
DIN 08086068
Director18 Dec 20196 yrs 10 moPatanjali Foods Limited
Gyan Sudha Misra
DIN 07577265
Director13 Aug 20206 yrs 2 moPatanjali Foods Limited
Tejendra Mohan Bhasin
DIN 03091429
Director13 Aug 20206 yrs 2 moPatanjali Foods Limited
Durga Shanker Mishra
DIN 02944212
Director14 Aug 20251 yr 2 moPatanjali Foods Limited
Baghrai Majhi
DIN 11125649
Nominee Director14 Aug 20251 yr 2 moPatanjali Foods Limited

IPO & Listings of Nutrela Nutrition

Nutrela Nutrition is a publicly listed company on the NSE with ticker symbol PATANJALI in India, operating in the FMCG sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: PATANJALI
  • Listed entityPatanjali Foods Limited
  • Exchange sectorFMCG

Financials of Nutrela Nutrition

Exchange-reported figures of Patanjali Foods Limited, the listed company behind Nutrela Nutrition (NSE: PATANJALI).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹40,170 Cr
+19.0% YoY
EBITDA
₹1,557 Cr
-20.4% YoY
Profit After Tax
₹1,951 Cr
+50.1% YoY
Net Worth
₹13,096 Cr
+15.2% YoY
Total Assets
₹15,942 Cr
+30.7% YoY
Total Debt
₹2,789 Cr
+254.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Income statement
Revenue40,17033,75812,72912,02719,17330,24031,561
Revenue growth+19.0%-+5.8%-37.3%-36.6%-4.2%-
EBITDA1,5571,95673.05(5,108)(758)158623
EBITDA margin+3.9%+5.8%+0.6%-42.5%-4.0%+0.5%+2.0%
Profit before tax1,3541,726(87.95)(6,186)(1,736)(1,309)102
Net profit1,9511,300(9.74)(5,637)(1,354)(1,270)37.58
Net profit margin+4.9%+3.9%-0.1%-46.9%-7.1%-4.2%+0.1%
EPS (₹)16.6835.920.000.000.000.002.36
Balance sheet
Total assets15,94212,1963,8643,1576,7528,3486,755
Net worth13,09611,371(4,717)(4,705)9242,4322,256
Total debt2,7897888,8638,0785,9215,8634,187
Cash & bank777296431178160313578
Net working capital9,2225,940(1,571)(2,460)1,3873,1304,151
Cash flow
Cash from operations(333)197225979441(412)(271)
Cash from investing(840)(14.03)(98.18)(68.14)86.3217.17104
Cash from financing1,680(611)(6.99)(970)(669)563(3.20)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11,33711,15610,4849,7778,7669,6928,9978,102
Revenue growth (YoY)+29.3%+15.1%+16.5%+20.7%+22.1%---
Other income4.4456.5757.4151.2312.9952.5323.5131.21
EBITDA543277404552321516558462
EBITDA margin+4.8%+2.5%+3.9%+5.6%+3.7%+5.3%+6.2%+5.7%
Depreciation53.2561.5762.1062.9061.8385.2769.7156.45
Interest41.2535.8835.2235.3223.7525.1220.2920.13
Profit before tax453236364505249458491417
Tax117(288)(229)(11.60)68.2199.95120108
Net profit336524593517180359371309
EPS (₹)3.094.825.454.751.669.9110.242.84
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue40,17033,75831,74231,52524,20516,31913,118
Revenue growth+19.0%+6.4%+0.7%+30.2%+48.3%+24.4%-
EBITDA1,5571,9571,3071,2871,491956401
EBITDA margin+3.9%+5.8%+4.1%+4.1%+6.2%+5.9%+3.1%
Profit before tax1,3541,7261,0601,1791,0745147,658
Net profit1,9511,301764892805680229
Net profit margin+4.9%+3.9%+2.4%+2.8%+3.3%+4.2%+1.7%
EPS (₹)16.6835.9421.1424.4927.2623.02259.40
Balance sheet
Total assets15,94312,19711,28411,41710,2168,0587,310
Net worth13,09711,37210,2059,9256,3494,2253,518
Total debt2,7897881,0491,3763,5183,4983,467
Cash & bank7462758341,1412,016387455
Net working capital9,1915,9194,7795,9815,0752,7252,038
Cash flow
Cash from operations(333)1981,746(339)724241(60.88)
Cash from investing(851)(35.60)(912)526(1,562)(41.57)(25.77)
Cash from financing1,680(611)(1,100)2411,167(307)82.42
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11,33711,15610,4849,7778,7669,6928,9978,102
Revenue growth (YoY)+29.3%+15.1%+16.5%+20.7%+22.1%---
Other income4.4456.5757.4151.2312.9952.5323.5131.21
Total expenses10,79410,87910,0799,2258,4459,1768,4397,639
EBITDA543277404552321516558463
EBITDA margin+4.8%+2.5%+3.9%+5.6%+3.7%+5.3%+6.2%+5.7%
Depreciation53.2461.5762.1062.9061.8385.2769.7156.45
Interest41.2535.8835.2235.3223.7525.1220.2920.13
Profit before tax453236365505249458491417
Tax117(288)(229)(11.60)68.2199.95120108

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 03 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11,33711,15610,4849,7778,7669,6928,9978,102
Revenue growth (YoY)+29.3%+15.1%+16.5%+20.7%+22.1%---
Other income4.4456.5757.4151.2312.9952.5323.5131.21
EBITDA543277404552321516558462
EBITDA margin+4.8%+2.5%+3.9%+5.6%+3.7%+5.3%+6.2%+5.7%
Depreciation53.2561.5762.1062.9061.8385.2769.7156.45
Interest41.2535.8835.2235.3223.7525.1220.2920.13
Profit before tax453236364505249458491417
Tax117(288)(229)(11.60)68.2199.95120108
Net profit336524593517180359371309
EPS (₹)3.094.825.454.751.669.9110.242.84
ParticularsFY 2025-26FY 2024-25FY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Revenue40,17033,75812,72912,02719,17330,24031,561
Revenue growth+19.0%-+5.8%-37.3%-36.6%-4.2%-
Other income17813212036.8915299.52252
Total expenses38,61331,80212,65617,13519,93130,08230,938
Employee cost638553153160193224225
EBITDA1,5571,95673.05(5,108)(758)158623
EBITDA margin+3.9%+5.8%+0.6%-42.5%-4.0%+0.5%+2.0%
Depreciation248268138143159167160
Interest13394.801439719721,439613
Profit before tax1,3541,726(87.95)(6,186)(1,736)(1,309)102
Tax(461)4250.02(437)(374)(80.16)24.88
Net profit1,9511,300(9.74)(5,637)(1,354)(1,270)37.58
Net profit margin+4.9%+3.9%-0.1%-46.9%-7.1%-4.2%+0.1%
EPS (₹)16.6835.920.000.000.000.002.36
ParticularsFY 2025-26FY 2024-25FY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Equity & liabilities
Share capital21872.4266.9366.8367.2965.2968.81
Reserves & surplus12,87911,298(4,784)(4,772)8572,3672,187
Shareholders' funds (net worth)13,09611,371(4,717)(4,705)9242,4322,256
Minority interest0.000.00(304)(226)(109)(58.39)98.38
Secured loans2,3857788,8048,0185,0693,4181,836
Unsecured loans4049.6259.6259.618522,4462,351
Total debt2,7897888,8638,0785,9215,8634,187
Total liabilities15,94212,1963,8643,1576,7528,3486,755
Assets
Gross block7,6327,4316,0296,0586,0676,0513,990
Net block5,3665,5535,2415,3895,5375,6702,455
Capital work in progress50.7094.6326.9128.1229.1642.02112
Investments24.4915831.2244.0449.9890.65153
Inventories7,2826,2101,2621,1911,2392,4813,160
Sundry debtors2,4071,5852642835,2856,8196,757
Cash & bank balances777296431178160313578
Loans & advances1,6161,1705715231,0291,6291,505
Total current assets12,0829,2622,5282,1767,71311,24211,999
Total current liabilities2,8603,3214,1004,6366,3268,1127,848
Net working capital9,2225,940(1,571)(2,460)1,3873,1304,151
Total assets15,94212,1963,8643,1576,7528,3486,755
ParticularsFY 2025-26FY 2024-25FY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Opening cash10953739.0098.3823970.78278
Net cash from operating activities(333)197225979441(412)(271)
Net cash from investing activities(840)(14.03)(98.18)(68.14)86.3217.17104
Net cash from financing activities1,680(611)(6.99)(970)(669)563(3.20)
Net change in cash507(428)120(59.38)(141)168(169)
Closing cash777296431178160313578
ParticularsFY 2025-26FY 2024-25FY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Growth
Sales growth+19.0%-+5.8%-37.3%-36.6%-4.2%-
EBITDA growth-20.4%-+101.4%-574.2%-578.6%-74.6%-
PBT growth-21.6%+9998.0%+98.6%-256.3%-32.6%-+158.8%
Net income growth+50.1%-+99.8%-316.4%-6.6%-3478.7%-
Revenue CAGR (3Y)+49.5%+20.8%-25.1%-27.5%-12.4%+0.4%-
EBITDA CAGR (3Y)---22.7%---40.6%-
Profitability & leverage
Net income margin+4.5%+3.9%-0.7%-47.8%-7.1%-4.2%+0.3%
Return on capital employed+12.0%+14.9%0.0%0.0%0.0%-0.5%+10.2%
Return on net worth+16.0%+11.4%0.0%0.0%0.0%-59.5%+1.5%
Debt / equity0.150.070.000.003.512.151.74
Long-term debt / equity0.000.000.000.000.050.170.40
Interest cover10.185.62-217.95-18.50-106.03-17,191.88132.33
Efficiency & per share
Fixed asset turnover5.334.542.111.983.166.037.98
Inventory turnover5.955.4410.389.9010.3110.729.17
Debtors turnover20.1321.3046.524.323.174.455.30
EPS (₹)16.6835.920.000.000.000.002.36
Dividend per share (₹)5.5010.000.000.000.000.160.16
Book value per share (₹)120.38314.03(144.54)(144.17)28.2672.8567.27
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11,33711,15610,4849,7778,7669,6928,9978,102
Revenue growth (YoY)+29.3%+15.1%+16.5%+20.7%+22.1%---
Other income4.4456.5757.4151.2312.9952.5323.5131.21
Total expenses10,79410,87910,0799,2258,4459,1768,4397,639
EBITDA543277404552321516558463
EBITDA margin+4.8%+2.5%+3.9%+5.6%+3.7%+5.3%+6.2%+5.7%
Depreciation53.2461.5762.1062.9061.8385.2769.7156.45
Interest41.2535.8835.2235.3223.7525.1220.2920.13
Profit before tax453236365505249458491417
Tax117(288)(229)(11.60)68.2199.95120108
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue40,17033,75831,74231,52524,20516,31913,118
Revenue growth+19.0%+6.4%+0.7%+30.2%+48.3%+24.4%-
Other income17813222029779.0164.347,505
Total expenses38,61231,80130,43530,23822,71515,36312,717
Employee cost638553354278186140153
EBITDA1,5571,9571,3071,2871,491956401
EBITDA margin+3.9%+5.8%+4.1%+4.1%+6.2%+5.9%+3.1%
Depreciation248268269160137133136
Interest13394.80198245358373113
Profit before tax1,3541,7261,0601,1791,0745147,658
Tax(461)425295293268(166)(14.00)
Net profit1,9511,301764892805680229
Net profit margin+4.9%+3.9%+2.4%+2.8%+3.3%+4.2%+1.7%
EPS (₹)16.6835.9421.1424.4927.2623.02259.40
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital21872.4272.38151237221207
Reserves & surplus12,88011,29910,1339,7744,8224,0033,312
Shareholders' funds (net worth)13,09711,37210,2059,9256,3494,2253,518
Secured loans2,3857789661,2742,9893,4943,017
Unsecured loans4049.6282.291025293.99450
Total debt2,7897881,0491,3763,5183,4983,467
Total liabilities15,94312,19711,28411,41710,2168,0587,310
Assets
Gross block7,5897,3946,5766,4946,0926,0135,998
Net block5,3235,5164,9635,1484,9004,9545,070
Capital work in progress50.7094.6310179.5927.9726.8325.20
Investments1242231,04137.5441.7130.3920.19
Inventories7,2826,2103,7684,0702,9052,3631,355
Sundry debtors2,4071,5851,4341,598796438274
Cash & bank balances7462758341,1412,016387455
Loans & advances1,6161,170721999621488512
Total current assets12,0519,2416,7577,8076,3393,6762,596
Total current liabilities2,8603,3211,9781,8261,264951558
Net working capital9,1915,9194,7795,9815,0752,7252,038
Total assets15,94312,19711,28411,41710,2168,0587,310
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash88.2253780337546.27154158
Net cash from operating activities(333)1981,746(339)724241(60.88)
Net cash from investing activities(851)(35.60)(912)526(1,562)(41.57)(25.77)
Net cash from financing activities1,680(611)(1,100)2411,167(307)82.42
Net change in cash497(449)(266)428329(108)(4.22)
Closing cash7462758341,1412,016387455
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+19.0%+6.4%+0.7%+30.2%+48.3%+24.4%-
EBITDA growth-20.4%+49.8%+1.6%-13.7%+55.9%+138.2%-
PBT growth-21.6%+62.8%-10.1%+9.7%+108.9%-93.3%+9881.8%
Net income growth+50.0%+70.1%-14.3%+10.8%+18.4%+197.1%-
Revenue CAGR (3Y)+8.4%+11.7%+24.8%+34.0%+23.9%+10.8%-10.9%
EBITDA CAGR (3Y)+6.6%+9.5%+11.0%+47.5%+130.1%--
Profitability & leverage
Net income margin+4.5%+3.9%+2.4%+2.8%+3.3%+4.2%+58.5%
Return on capital employed+12.0%+15.5%+11.1%+13.2%+15.7%+11.5%+4.0%
Return on net worth+16.0%+12.1%+7.6%+11.1%+15.8%+18.3%+10.6%
Debt / equity0.150.090.120.300.660.900.00
Long-term debt / equity0.000.000.000.160.490.710.00
Interest cover10.185.6119.0321.7226.4845.2942.44
Efficiency & per share
Fixed asset turnover5.364.834.865.014.002.722.19
Inventory turnover5.956.778.109.049.198.7810.03
Debtors turnover20.1322.3620.9426.3439.2145.8148.93
EPS (₹)16.6835.9421.1424.4927.2623.02259.40
Dividend per share (₹)3.7510.006.006.005.000.000.00
Book value per share (₹)120.39314.04281.98272.07165.03137.35113.97

Web traffic of Nutrela Nutrition

Websites that share an audience with Nutrela Nutrition (nutrelanutrition.com).

Similar websites

Websites whose visitors overlap most with Nutrela Nutrition. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
TruNativ
trunativ.co
100%
126.9K#278,504View details
Pure Nutrition
purenutrition.in
100%
194.9K#144,461View details
My Little Moppet
mylittlemoppet.com
98%
116.1K#357,860View details
HealthyHey
healthyhey.com
96%
64.9K#486,448View details
Kapiva
kapiva.in
90%
3.5M#16,572View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 35 similar websites and full traffic analytics for Nutrela Nutrition

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 35 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Nutrela Nutrition (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Schwabe India
Homeopathic medicine manufacturing and online retail in India.
1898Noida, Uttar Pradesh, IndiaUSD 26.35 M1,192
Healthmug
Operates an online store specializing in ayurvedic and homeopathic medicines.
2016Delhi, Delhi, IndiaUSD 1.25 M16
Jiva Ayurveda
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.
1992Faridabad, Haryana, IndiaUSD 10.08 M570
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nutrela Nutrition

GLOBOIL India 2026 Concludes in Mumbai as the GLOBOIL Awards 2026 Honour the Leaders of the Global Edible Oil Trade
Business Standard • 28 days ago
Sansera Engineering Ltd leads losers in 'A' group | Capital Market News - Business Standard
Business Standard • 1 month ago
Patanjali Foods, AWL Agri shares under pressure as centre cuts edible oil import duty
ZEE Business • 1 month ago
Here's why Patanjali Foods, AWL Agri and Godrej Agrovet shares will be in focus today - CNBC TV18
CNBCTV18 • 1 month ago
Why SBI lost its Rs 1,759-crore insolvency case against Patanjali Foods guarantor despite debt remaining alive
Moneycontrol • 1 month ago
Patanjali: Jefferies on Patanjali Maintains Buy with Target Price of ₹560 as management expects festive-led rural recovery, while maintaining FY27 volume growth guidance of 4% for Edible Oil, 8–10% for Foods and 15% for FMCG HPC, with FMCG HPC margins expected at 18–20%.
Exchange Update • 1 month ago
Patanjali Foods Ltd rises for third consecutive session | Capital Market News - Business Standard
Business Standard • 1 month ago
Patanjali Foods maintains 15% FMCG growth guidance despite rural weakness, says CEO Sanjeev Asthana - CNBC TV18
CNBCTV18 • 1 month ago
Patanjali Foods Shares Rally 6% as Management Reaffirms FY27 Growth Targets and Forecasts Strong Free Cash Flow
Moneycontrol • 1 month ago
Patanjali Foods: Co Says Rural Demand And Sunflower Oil Remain Weak, While Poor Monsoon And 90% Margin Pressure Could Lead To Lower Guidance Post Q2. - Interview
Exchange Update • 1 month ago
Premium access

Complete news archive for Nutrela Nutrition

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nutrela Nutrition

Nutrela Nutrition is headquartered in India.

Nutrela Nutrition has 5,564 employees.

The primary company behind Nutrela Nutrition, Patanjali Foods Limited, reported revenue of ₹40,348 Cr for FY 2026, up 19% year on year.

Patanjali Foods Limited is known for the production of certified organic and natural nutraceutical products that are based on Ayurvedic principles and scientific research. These products, including supplements for men, women, and children, are designed to address daily nutritional needs and promote health without relying on chemicals. A range of items such as proteins, vitamins, and herbal formulations is made available to support immunity, muscle health, and overall well-being in todays fast-paced lifestyle. Eco-friendly practices are adopted in their manufacturing processes to ensure safety and effectiveness.

Nutrela Nutrition offers Nutritional Supplements and Ayurvedic Supplements.

Yes, Nutrela Nutrition is publicly traded on NSE under the ticker symbol PATANJALI.

Nutrela Nutrition operates through Patanjali Foods Limited.

The legal entities of Nutrela Nutrition currently have 11 directors, including Girish Kumar Ahuja, Acharya Balkrishna, Ram Bharat and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available